Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2001, for Owens & Minor, Inc. (O&M), a distributor of medical and surgical supplies. The filing includes unaudited consolidated financial statements for the three and six months ended June 30, 2001, compared to the same periods in 2000. The company operates through wholly-owned subsidiaries and focuses on providing value-added services to healthcare providers.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2001 | Six Months Ended June 30, 2001 |
|---|---|---|
| Net Sales | $953.5 million | $1.878 billion |
| Gross Margin | $100.7 million (10.6%) | $199.6 million (10.6%) |
| Net Income | $9.4 million | $17.1 million |
| Diluted EPS | $0.26 | $0.48 |
| Operating Cash Flow (6mo) | $8.2 million | |
| Long-Term Debt | $156.1 million | |
| Off-Balance Sheet Receivables Sold | $105.0 million | |
| Working Capital | $260.4 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9% in the second quarter and 8% in the first six months of 2001 compared to 2000, driven by penetration of existing accounts and new business.
- Profitability: Net income rose 17.5% in the quarter and 15.4% for the six-month period. Excluding restructuring credits, net income increased due to sales growth and controlled financing costs.
- Margins: Gross margin percentage remained consistent at 10.6% for the quarter but dipped slightly to 10.6% for the six-month period (from 10.7% in 2000) due to decreased customer contract margins, partially offset by vendor initiatives.
- Operating Cash Flow: Cash provided by operating activities dropped significantly to $8.2 million for the six months ended June 30, 2001, from $48.2 million in the prior year. This was primarily due to a $62.7 million increase in merchandise inventories to support sales growth.
- Restructuring: The company recorded a restructuring credit of $1.5 million in the second quarter of 2001 due to a re-evaluation of costs related to a 1998 downsizing plan.
Guidance, Outlook, and Risks
- Capital Structure Update: In July 2001, the company issued $200 million of 8.5% Senior Subordinated Notes due 2011. Proceeds were used to retire $150 million of 10.875% notes due 2006 and reduce receivables sold under the financing facility. This transaction will result in an extraordinary loss of approximately $7 million in the third quarter of 2001.
- Liquidity: The company maintains $218.9 million in unused credit under its revolving facility and the ability to sell an additional $120 million in receivables. Management expects available financing to be sufficient for working capital and strategic growth.
- Accounting Changes: The company will adopt SFAS 142 (Goodwill and Other Intangible Assets) on January 1, 2002, which will eliminate goodwill amortization expense. Management does not currently anticipate a transitional impairment loss.
- Risks: Key risks include cost-control pressures in the medical industry, dependence on large customers, and a pending IRS appeal regarding corporate-owned life insurance (COLI) deductions. An adverse resolution of the IRS matter could impact results by approximately $8.8 million after tax.
Investor Verification Checklist
- Inventory Build: Verify the necessity and turnover rates of the $62.7 million increase in inventory, which significantly impacted operating cash flow.
- Debt Refinancing Impact: Confirm the timing and magnitude of the $7 million extraordinary loss related to the early retirement of the 2006 notes in the upcoming quarter.
- IRS Contingency: Monitor the status of the IRS appeal regarding COLI deductions, which poses a potential $8.8 million after-tax liability.
- Margin Pressure: Assess the sustainability of gross margins given the noted decrease in customer contract margins.
- Goodwill Impairment: Review the upcoming SFAS 142 adoption assessment for potential goodwill impairment charges in 2002.